---
figid: PMC11391512__mmr-30-05-13319-g02
pmcid: PMC11391512
image_filename: mmr-30-05-13319-g02.jpg
figure_link: /pmc/articles/PMC11391512/figure/F3/
number: Figure 3.
figure_title: Analysis of metabolic pathways and metabolites of PAH affected by OA.
caption: Analysis of metabolic pathways and metabolites of PAH affected by OA. (A)
  Metabolic pathway analysis between the Control group and the PAH group. (B) Hierarchical
  clustering of differential metabolites involved in glucose metabolic pathways for
  each group. OA, oroxylin A; PAH, pulmonary arterial hypertension; DCA, Dichloroacetate
article_title: Oroxylin A, a broad‑spectrum anticancer agent, relieves monocrotaline‑induced
  pulmonary arterial hypertension by inhibiting the Warburg effect in rats
citation: Yan Wang, et al. Mol Med Rep. 2024 Nov;30(5).
year: '2024'
pub_date: 2024-11-
epub_date: 2024-8-30
doi: 10.3892/mmr.2024.13319
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos
keywords:
- pulmonary arterial hypertension
- oroxylin A
- metabolomics
- Warburg effect
- glycolysis
---
